NCT02205437 Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia Status UNKNOWN Phase N/A
NCT02205099 A Safety, Tolerability, PK and PD Study of Multiple Oral Doses of SKL15508 in Subjects With Stable Schizophrenia Status COMPLETED Phase PHASE1/PHASE2
NCT02203838 Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia Status COMPLETED Phase PHASE3
NCT02202226 Safety and Tolerability Study of Lu AF35700 After Repeated Dosing in Patients With Schizophrenia Status COMPLETED Phase PHASE1
NCT02202213 Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With Schizophrenia Status COMPLETED Phase PHASE1
NCT02201888 Effects of a Cognitive Rehabilitation Program: a Neurocognitive Study Status COMPLETED Phase NA
NCT02200588 Longitudinal Long-term Study (10 Years) of the Sample of First Episode of Non-affective Psychosis: PAFIP Status UNKNOWN Phase N/A
NCT02199704 Self Directed Positive Parenting Program (Triple P) for Psychosis: A Clinical Case Series Status COMPLETED Phase NA
NCT02197286 Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia Status WITHDRAWN Phase PHASE2
NCT02192723 A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia Status COMPLETED Phase NA
NCT02188732 Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes Status COMPLETED Phase NA
NCT02188121 Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients Status COMPLETED Phase PHASE4
NCT02187692 The Effectiveness of the Meta-cognitive Training Among Patients With Chronic Schizophrenia Status COMPLETED Phase NA
NCT02186769 An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder Status COMPLETED Phase PHASE1
NCT02181803 Elpipodect (MK-8189) Multiple Dose Study in Healthy Volunteers and Schizophrenia Participants (MK-8189-003) Status COMPLETED Phase PHASE1
NCT02176044 The Effect of Nitric Oxide on Spatial Working Memory in Patients With Schizophrenia - Pilot Study Status COMPLETED Phase PHASE1